IDENTIFICATION OF 5-DEOXY-D-RIBITOL AS A MAJOR METABOLITE OF 5'-DEOXY-5-FLUOROURIDINE IN RATS

被引:0
|
作者
ICHIHARA, S
ICHIHARA, Y
TOMISAWA, H
FUKAZAWA, H
TATEISHI, M
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:520 / 521
页数:2
相关论文
共 50 条
  • [21] SYNTHESIS AND GAMMA-RADIOLYSIS OF 2'-DEOXY-5-FLUOROURIDINE AND 5-FLUOROURIDINE DERIVATIVES
    KURODA, T
    HISAMURA, K
    MATSUKUMA, I
    NISHIKAWA, H
    MORIMOTO, M
    ASHIZAWA, T
    NAKAMIZO, N
    OTSUJI, Y
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1992, 29 (05) : 1133 - 1142
  • [22] TUMOR INHIBITORY EFFECTS OF A NEW FLUOROURACIL DERIVATIVE - 5'-DEOXY-5-FLUOROURIDINE
    BOLLAG, W
    HARTMANN, HR
    EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) : 427 - 432
  • [23] ACTIVATION OF 5'-DEOXY-5-FLUOROURIDINE BY THYMIDINE PHOSPHORYLASE IN HUMAN-TUMORS
    KONO, A
    HARA, Y
    SUGATA, S
    KARUBE, Y
    MATSUSHIMA, Y
    ISHITSUKA, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1983, 31 (01) : 175 - 178
  • [24] INCREASED CYTOTOXICITY OF 5'-DEOXY-5-FLUOROURIDINE BY PROLONGED CULTURE WITH FOLINIC ACID
    MATSUOKA, H
    FURUSAWA, M
    TOMODA, H
    SEO, Y
    SUGIMACHI, K
    ANTICANCER RESEARCH, 1993, 13 (6A) : 2201 - 2206
  • [25] 5'-DEOXY-5-FLUOROURIDINE - A MODEL SUBSTRATE FOR THE STUDY OF PYRIMIDINE NUCLEOSIDE TRANSPORT
    BOWEN, D
    ENIGBOKAN, MA
    DIASIO, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 219 - 219
  • [26] PHARMACOLOGY OF 5'-DEOXY-5-FLUOROURIDINE IN PATIENTS WITH RESISTANT OVARIAN-CANCER
    DEBRUIJN, EA
    VANOOSTEROM, AT
    TJADEN, UR
    REEUWIJK, HJEM
    PINEDO, HM
    CANCER RESEARCH, 1985, 45 (11) : 5931 - 5935
  • [27] PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF 5'-DEOXY-5-FLUOROURIDINE
    ABELE, R
    ALBERTO, P
    SEEMATTER, RJ
    HEINTZ, R
    GERMANO, G
    WEBER, W
    OBRECHT, JP
    CANO, JP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 178 - 178
  • [28] METABOLISM AND BIOLOGICAL-ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE, A NOVEL FLUOROPYRIMIDINE
    ARMSTRONG, RD
    DIASIO, RB
    CANCER RESEARCH, 1980, 40 (09) : 3333 - 3338
  • [29] EVIDENCE THAT 5'-DEOXY-5-FLUOROURIDINE MAY NOT BE ACTIVATED BY THE SAME MECHANISM AS 5-FLUOROURACIL
    CORY, JG
    CARTER, GL
    BIOCHEMICAL PHARMACOLOGY, 1982, 31 (17) : 2841 - 2844
  • [30] Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5′-deoxy-5-fluorouridine (5′-DFUR)
    Hiromichi Ebi
    Yasushi Sigeoka
    Toshiaki Saeki
    Kenji Kawada
    Tadahiko Igarashi
    Noriko Usubuchi
    Ryuzo Ueda
    Yasutsuna Sasaki
    Hironobu Minami
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 205 - 211